The U.S. has given Merck a $356 million contract to supply up to 100,000 doses of an investigational drug that helped severe COVID-19 patients recover in clinical trials.
A Boston physician had a severe allergic reaction after receiving a COVID-19 vaccine from Moderna.
Novavax has started a phase 3 clinical trial for its COVID-19 vaccine candidate in the U.S.
Pfizer-BioNTech and Moderna’s COVID-19 vaccines will likely hold up against the fast-spreading variant first detected in the U.K.
More articles on healthcare:
What ASC execs need to know about the COVID-19 relief bill: 6 details
USPI headed in 2021: 8 things to know
California surgery center remains open, despite system’s elective surgery postponement
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
